161 related articles for article (PubMed ID: 33779091)
21. Clinicopathologic features of ovarian Sertoli-Leydig cell tumors.
Zhang HY; Zhu JE; Huang W; Zhu J
Int J Clin Exp Pathol; 2014; 7(10):6956-64. PubMed ID: 25400781
[TBL] [Abstract][Full Text] [Related]
22. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
[TBL] [Abstract][Full Text] [Related]
23. Ovarian Sertoli-Leydig cell tumours: A systematic review of relapsed cases.
Nef J; Huber DE
Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():261-274. PubMed ID: 34245994
[TBL] [Abstract][Full Text] [Related]
24. Sertoli-Leydig cell tumor of ovary in children: A report of two cases, including retiform variant.
Sarkar P; Sengupta M; Chatterjee U; Ghosh D
Indian J Pathol Microbiol; 2021; 64(3):559-562. PubMed ID: 34341273
[TBL] [Abstract][Full Text] [Related]
25. Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature.
Grove A; Vestergaard V
Ann Diagn Pathol; 2006 Oct; 10(5):288-93. PubMed ID: 16979522
[TBL] [Abstract][Full Text] [Related]
26. Pediatric ovarian Sertoli-Leydig cell tumors with heterologous rhabdomyosarcoma elements: Clinical case series and review of the literature.
Koo J; Garrington TP; Kerr K; Treece AL; Cost CR
Pediatr Blood Cancer; 2020 Oct; 67(10):e28621. PubMed ID: 32729194
[TBL] [Abstract][Full Text] [Related]
27. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
28. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
[TBL] [Abstract][Full Text] [Related]
29. Sertoli - Leydig cell tumor with retiform areas and overgrowth of rhabdomyosarcomatous elements: case report and literature review.
Burnik Papler T; Frković Grazio S; Kobal B
J Ovarian Res; 2016 Jul; 9(1):46. PubMed ID: 27473538
[TBL] [Abstract][Full Text] [Related]
30. Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries.
Nelson AT; Harris AK; Watson D; Kamihara J; Chen KS; Stall JN; Devins KM; Young RH; Olson DR; Mallinger PHR; Mitchell SG; Hoffman LM; Halliday G; Suleymanova AM; Glade Bender JL; Messinger YH; Herzog CE; Field AL; Frazier AL; Stewart DR; Dehner LP; Hill DA; Billmire DF; Schneider DT; Schultz KAP
Gynecol Oncol; 2024 Apr; 186():117-125. PubMed ID: 38657450
[TBL] [Abstract][Full Text] [Related]
31. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.
Bhat RA; Lim YK; Chia YN; Yam KL
J Obstet Gynaecol Res; 2013 Jan; 39(1):305-10. PubMed ID: 22691037
[TBL] [Abstract][Full Text] [Related]
32. Imaging in gynecological disease (27): clinical and ultrasound characteristics of recurrent ovarian stromal cell tumors.
Moro F; Giudice MT; Bolomini G; Moruzzi MC; Mascilini F; Quagliozzi L; Ciccarone F; Scambia G; Fagotti A; Valentin L; Testa AC
Ultrasound Obstet Gynecol; 2024 Mar; 63(3):399-407. PubMed ID: 37774092
[TBL] [Abstract][Full Text] [Related]
33. Imaging, clinical, and pathologic findings of Sertoli-leydig cell tumors.
Chen J; Liu Y; Zhang Y; Wang Y; Chen X; Wang Z
Sci Prog; 2021; 104(2):368504211009668. PubMed ID: 33848213
[TBL] [Abstract][Full Text] [Related]
34. Trisomy 8 as sole karyotypic aberration in an ovarian metastasizing Sertoli-Leydig cell tumor.
Manegold E; Tietze L; Günther K; Fleischer A; Amo-Takyi BK; Schröder W; Handt S
Hum Pathol; 2001 May; 32(5):559-62. PubMed ID: 11381376
[TBL] [Abstract][Full Text] [Related]
35. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
[No Abstract] [Full Text] [Related]
36. Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT).
Schneider DT; Orbach D; Cecchetto G; Stachowicz-Stencel T; Brummel B; Brecht IB; Bisogno G; Ferrari A; Reguerre Y; Godzinski J; Bien E; Calaminus G; Göbel U; Patte C
Eur J Cancer; 2015 Mar; 51(4):543-550. PubMed ID: 25514863
[TBL] [Abstract][Full Text] [Related]
37. Metastatic rhabdomyosarcomatous elements, mimicking a primary sarcoma, in the omentum, from a poorly differentiated ovarian Sertoli-Leydig cell tumor in a young girl: an unusual presentation with a literature review.
Rekhi B; Karpate A; Deodhar KK; Chinoy RF
Indian J Pathol Microbiol; 2009; 52(4):554-8. PubMed ID: 19805972
[TBL] [Abstract][Full Text] [Related]
38. Mesenteric extraovarian Sertoli-Leydig cell tumor without DICER1 hotspot mutation: a case report.
Osakabe M; Sato C; Suzuki M; Sugimoto R; Fujita Y; Uesugi N; Ishida K; Itamochi H; Baba T; Sugai T
Diagn Pathol; 2019 Apr; 14(1):27. PubMed ID: 30935425
[TBL] [Abstract][Full Text] [Related]
39. Sertoli-Leydig cell tumors of ovary: A case series.
Xu Q; Zou Y; Zhang XF
Medicine (Baltimore); 2018 Oct; 97(42):e12865. PubMed ID: 30334998
[TBL] [Abstract][Full Text] [Related]
40. A Report of Ovarian Sertoli-Leydig Cell Tumors With Heterologous Intestinal-type Glands and Alpha Fetoprotein Elevation and Review of the Literature.
Al-Hussaini M; Al-Othman Y; Hijazi E; McCluggage WG
Int J Gynecol Pathol; 2018 May; 37(3):275-283. PubMed ID: 28582340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
